The Federal Circuit Bar Association (FCBA) will be offering a remote program entitled "Patents in the Time of COVID-19: How the Crisis is Shaping IP, Innovation, and Access to Medicine Now, and for the Future" on May 7, 2020 from 11:00 am to 12:00 pm (EST). Ute Kilger of Boehmert & Boehmert will moderate a panel consisting of Robert DeBerardine of Johnson & Johnson, David Rosen of Foley & Lardner LLP, Corey Salsberg of Novartis, and Hans Sauer of the Biotechnology Innovation Organization (BIO). The panel will discuss the effects of patents on the development and on the availability of new medicaments and tests in times of COVID-19.
The webinar is complimentary for FCBA members, $25 for government/students, or $75 for private practitioners. Those interested in registering for the program, can do so here.
Comments